Donate Help Contact The AHA Sign In Home
American Heart Association
Stroke
Search: search_blue_button Advanced Search
Stroke. 1987;18:1169-1172

This Article
Right arrow Full Text (PDF)
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Right arrow Request Permissions
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Chimowitz, M. I.
Right arrow Articles by Pessin, M. S.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Chimowitz, M. I.
Right arrow Articles by Pessin, M. S.

Stroke, Vol 18, 1169-1172, Copyright © 1987 by American Heart Association


ARTICLES

Is there a role for heparin in the management of complications of subarachnoid hemorrhage?

MI Chimowitz and MS Pessin
Department of Neurology, New England Medical Center, Boston, MA 02111.

Proven effective therapy to prevent ischemic deficits and other complications after subarachnoid hemorrhage is lacking despite extensive research efforts. A literature review documented both clinical and experimental evidence suggesting that heparin may be effective in preventing ischemic deficits after subarachnoid hemorrhage by reversing vasospasm, improving blood flow through narrowed vessels, and preventing the development of a proliferative angiopathy. Additional evidence suggests that heparinization of the cerebrospinal fluid following subarachnoid hemorrhage may prevent the development of hydrocephalus. In the only clinical trial using heparin after subarachnoid hemorrhage, the incidence of rebleeding in the heparinized patients was no higher than in the control group. We conclude that the existing preliminary data concerning a role for heparin in the management of the complications of subarachnoid hemorrhage is promising, but further controlled studies are needed prior to clinical application.


This article has been cited by other articles:


Home page
StrokeHome page
E. Busch, C. Beaulieu, A. de Crespigny, M. E. Moseley, and J. P. Muizelaar
Diffusion MR Imaging During Acute Subarachnoid Hemorrhage in Rats • Editorial Comment
Stroke, October 1, 1998; 29(10): 2155 - 2161.
[Abstract] [Full Text] [PDF]